The Hallmarks of BPH Progression and Risk Factors M. Emberton  European Urology Supplements  Volume 2, Issue 8, Pages 2-7 (November 2003) DOI: 10.1016/j.eursup.2003.09.008

Fig. 1 Changes in BPH symptom severity with age in the Olmsted County Study [4] (*p<0.001 vs. baseline). European Urology Supplements 2003 2, 2-7DOI: (10.1016/j.eursup.2003.09.008)

Fig. 2 Mean percentage increase in prostate volume over 4 years among men in the placebo arm of the PLESS trial (*mean prostate volume = 41.4ml). Reproduced with permission from McConnell JD et al. N Engl J Med 1998:338;557–563. European Urology Supplements 2003 2, 2-7DOI: (10.1016/j.eursup.2003.09.008)

Fig. 3 Correlation between symptom severity and poor quality of life in men with BPH. Reproduced with permission from Girman CJ et al. Urology 1994;44:825–831. European Urology Supplements 2003 2, 2-7DOI: (10.1016/j.eursup.2003.09.008)

Fig. 4 Serum PSA as a predictor of prostate growth in men in the placebo arm of the PLESS [15]. European Urology Supplements 2003 2, 2-7DOI: (10.1016/j.eursup.2003.09.008)